
Clonmel-based Shorla Oncology to increase revenues significantly
The CEO of Shorla Oncology said on Thursday that the business expects to increase revenues significantly in 2025. Ms Sharon Cunningham was commenting on new accounts for the Clonmel-headquartered Shorla Pharma Ltd which show that the group recorded a pre- …